Package 0093-0109-10

{"route": ["ORAL"], "spl_id": "042aa2c6-95ff-410a-abcf-a8ee79fa96d8", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["308973", "308979"], "spl_set_id": ["bfd63965-56e6-4af7-b7ef-45a5105d4d35"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0093-0109-01)", "package_ndc": "0093-0109-01", "marketing_end_date": "20260630", "marketing_start_date": "19900930"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (0093-0109-10)", "package_ndc": "0093-0109-10", "marketing_end_date": "20260731", "marketing_start_date": "19900930"}], "brand_name": "Carbamazepine", "product_id": "0093-0109_042aa2c6-95ff-410a-abcf-a8ee79fa96d8", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0093-0109", "generic_name": "Carbamazepine", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Carbamazepine", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA070541", "marketing_category": "ANDA", "marketing_end_date": "20260731", "marketing_start_date": "19900930"}